Seer Inc. (SEER)
undefined
undefined%
At close: undefined
2.47
0.00%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome.

It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials.

The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes.

It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies.

The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018.

Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Seer Inc.
Seer Inc. logo
Country United States
IPO Date Dec 4, 2020
Industry Biotechnology
Sector Healthcare
Employees 147
CEO Dr. Omid C. Farokhzad M.D., Ph.D.

Contact Details

Address:
3800 Bridge Parkway
Redwood City, California
United States
Website https://seer.bio

Stock Details

Ticker Symbol SEER
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001726445
CUSIP Number 81578P106
ISIN Number US81578P1066
Employer ID 82-1153150
SIC Code 3826

Key Executives

Name Position
Dr. Omid C. Farokhzad M.D., Ph.D. Founder, Chief Executive Officer, & Chair of the Board of Directors
David R. Horn President,Treasurer & Chief Financial Officer
Joe Laws Chief Technology Officer and Co-Founder
Marissa Dixon Chief People Officer
Dr. Asim Siddiqui Ph.D. Senior Vice President of Research & Tech Development
Dr. Serafim Batzoglou Ph.D. Chief Data Officer
Kenny Ross Chief Operations & Product Officer
Martin Goldberg Ph.D. Senior Vice President of Development

Latest SEC Filings

Date Type Title
Nov 06, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K Current Report
Oct 07, 2024 4 Filing
Oct 07, 2024 4 Filing
Oct 07, 2024 8-K Current Report
Aug 16, 2024 8-K Current Report
Aug 15, 2024 4 Filing
Aug 15, 2024 3 Filing
Aug 08, 2024 10-Q Quarterly Report
Aug 08, 2024 8-K Current Report